Drug Topics

DECEMBER 24, 2023

Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.

Vaccines 491

Vaccines Immunization 491

Drug Topics

JANUARY 17, 2023

The updates include new recommendations for COVID-19 and pneumococcal vaccines.

Immunization 503

Immunization Vaccines 503

Drug Topics

DECEMBER 26, 2023

Biologic approvals ranged from gene therapies for hemophilia A to a cellular therapy to treat type 1 diabetes.

503

503

Drug Topics

AUGUST 11, 2023

HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.

FDA 468

FDA 468

Drug Topics

JUNE 15, 2023

Meet this year’s Pharmacy of the Year nominees and preview some of the sessions available at this year’s meeting.

465

465

Drug Topics

DECEMBER 25, 2023

In addition to the numerous adalimumab (Humira) biosimilars that launched this year, multiple new biosimilar products were approved by the FDA in 2023.

FDA 281

FDA 281

Drug Topics

SEPTEMBER 30, 2023

As the Southern Hemisphere sees a mixed flu season, uncertainty looms for those in the North.

469

469

Drug Topics

MARCH 14, 2023

How are hiring trends shaping up for the future of health care?

469

469

Drug Topics

OCTOBER 4, 2022

Does the severe flu season in the southern hemisphere hint at a tough season for the north?

565

565

Drug Topics

SEPTEMBER 7, 2022

Keep your pharmacy vaccine-ready for your youngest patients with the most current influenza vaccination information from the American Academy of Pediatrics.

Vaccines 503

Vaccines 503

Drug Topics

FEBRUARY 1, 2023

A new report unpacks some of the challenges that independent pharmacists may face in the years ahead.

Independent Pharmacies 469

Independent Pharmacies 469

PharmaVoice

DECEMBER 12, 2022

Here’s a look at how industry leaders are navigating the key issues of 2023.

264

264

PharmaVoice

SEPTEMBER 19, 2023

This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.

363

363

Drug Topics

NOVEMBER 29, 2023

This season marks the fourth to be classified as high severity since the 2009 influenza A(H1N1) pandemic.

469

469

Drug Topics

JANUARY 11, 2023

Pharmacists can play an important role in patients’ wellness journeys.

501

501

Drug Topics

FEBRUARY 9, 2023

This year will be an exciting one for dermatologic therapy and pharmacology as treatments continue to evolve.

360

360

Drug Topics

SEPTEMBER 27, 2023

Watch pharmacists and vendors recap their APEX 2023 experience. APEX 2024 will be here before you know it.

247

247

Drug Topics

JANUARY 2, 2024

2023 was a year packed with advancements in the vaccine, biosimilar, and therapeutic spaces. Explore the approvals that emerged in 2023 from these advancements in our slideshow series outlining the impact of each on the general health care landscape.

Vaccines 247

Vaccines 247

Drug Topics

NOVEMBER 16, 2022

Inflation is the top reason that nearly one-third of Americans are concerned about covering unexpected health care needs.

437

437

Drug Topics

OCTOBER 25, 2023

This year's Luminary of the Year award winners were announced at the NCPA 2023 Annual Convention and Expo.

247

247

Drug Topics

OCTOBER 16, 2023

The winner was announced during the 2023 NCPA Annual Convention and Expo.

281

281

Drug Topics

OCTOBER 2, 2022

Jordan Cardinal, EM/CC PharmD, a Medical Science Liaison in Integrated Diagnostic Solutions at BD, joins Drug Topics® to discuss the current outlook on the upcoming 2022-2023 flu season, and how the prevalence of the BA.5 5 variant of the SARS-CoV-2 virus might affect the health care outlook over the coming months.

247

247

PhRMA

JANUARY 19, 2023

This January, PhRMA joined health care leaders, investors, R&D experts and members of the media at the 2023 J.P. Morgan Health Care Conference in San Francisco, CA. During this week, we discussed ways to improve patient outcomes, access and affordability in our health care system. Here are some highlights from the conference:

262

262

Drug Topics

SEPTEMBER 6, 2023

The CDC issues an alert for increased RSV activity, a survey finds men's habits don't stack up to their perceptions on their health, and the WHO announces an air pollution training course for health care workers.

281

281

PhRMA

JUNE 8, 2023

Last week, I traveled to the American Society of Clinical Oncology’s (ASCO) annual meeting. It’s always an exceptional meeting where the brightest minds in oncology, including researchers, health care providers and industry stakeholders gather to learn about the latest advancements in cancer research and development (R&D).

275

275

Drug Topics

FEBRUARY 23, 2024

Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.

582

582

Drug Topics

MAY 13, 2024

Altuviiio was first granted approval by the FDA in February 2023.

Labelling 503

Labelling FDA 503

Drug Topics

DECEMBER 7, 2023

A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.

582

582

PharmaVoice

OCTOBER 27, 2023

This year's inductees to the PharmaVoice 100 "hall of fame" are leaders who have been at the forefront — and will stay at the forefront — of industry change.

264

264

Drug Topics

DECEMBER 7, 2023

Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.

529

529

Drug Topics

SEPTEMBER 14, 2023

FDA sends warning letters to 8 companies over unapproved eye drops, healthcare visits delivered by nurse practitioners and physician assistants continue to increase, and WHO agrees on the first-ever patient safety rights charter.

FDA 247

FDA 247

Drug Topics

SEPTEMBER 13, 2023

The CDC weighs in on updated COVID-19 vaccines, the FDA says phenylephrine is ineffective, and heath care workers in California get a pay raise.

Vaccines 247

Vaccines FDA 247

Drug Topics

SEPTEMBER 12, 2023

CDC to weigh who should get updated COVID-19 vaccines after FDA approval, Novavax says its updated COVID-19 vaccine is ready for distribution, and Walgreens partners with Pearl Health to expand primary care services.

Vaccines 247

Vaccines FDA 247

Drug Topics

SEPTEMBER 8, 2023

CDC survey finds Interventions are needed to facilitate the implementation of updated pneumococcal vaccine recommendations, HHS proposes a new rule the seeks to prohibit discrimination based on disabilities, and a new report says there is a need for improved access to pediatric subspecialty care.

Vaccines 247

Vaccines 247

Drug Topics

SEPTEMBER 1, 2023

The FDA plans to finalize its ban on menthol tobacco products in the coming months, and the Department of Health and Human Services proposes comprehensive staffing requirements for nursing homes.

Nursing Homes 247

Nursing Homes FDA 247

Drug Topics

AUGUST 31, 2023

The FDA issues warning letters to 3 infant formula manufacturers for violations, and officials with the Department of Health and Human Services recommend reclassifying marijuana as a schedule III drug.

FDA 247

FDA 247

Drug Topics

AUGUST 30, 2023

Narcan is set to be available at several drugstore and grocery chains in the US early next week, and Walmart announced a new "Testing and Treatment" program at its pharmacies in 12 states.

247

247